VANI Vivani Medical Inc

Price (delayed)

$1.26

Market cap

$69.27M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.49

Enterprise value

$58.66M

Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in ...

Highlights
The equity has grown by 38% from the previous quarter but it has contracted by 25% YoY
The company's quick ratio rose by 32% QoQ but it fell by 25% YoY
Vivani Medical's net income has shrunk by 56% YoY

Key stats

What are the main financial stats of VANI
Market
Shares outstanding
54.98M
Market cap
$69.27M
Enterprise value
$58.66M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.41
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$25.37M
EBITDA
-$23.98M
Free cash flow
-$22.28M
Per share
EPS
-$0.49
Free cash flow per share
-$0.43
Book value per share
$0.52
Revenue per share
$0
TBVPS
$1.03
Balance sheet
Total assets
$53.79M
Total liabilities
$25.08M
Debt
$20.37M
Equity
$28.71M
Working capital
$25.36M
Liquidity
Debt to equity
0.71
Current ratio
5.13
Quick ratio
5.05
Net debt/EBITDA
0.44
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-47.8%
Return on equity
-93.9%
Return on invested capital
-65%
Return on capital employed
-53.2%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

VANI stock price

How has the Vivani Medical stock price performed over time
Intraday
2.44%
1 week
-3.08%
1 month
-1.56%
1 year
-0.79%
YTD
23.53%
QTD
0%

Financial performance

How have Vivani Medical's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$26.59M
Net income
-$25.37M
Gross margin
N/A
Net margin
N/A
Vivani Medical's net income has shrunk by 56% YoY
VANI's operating income is down by 11% YoY

Growth

What is Vivani Medical's growth rate over time

Valuation

What is Vivani Medical stock price valuation
P/E
N/A
P/B
2.41
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS is down by 32% year-on-year but it is up by 2% since the previous quarter
VANI's price to book (P/B) is 67% less than its 5-year quarterly average of 7.1 and 6% less than its last 4 quarters average of 2.5
The equity has grown by 38% from the previous quarter but it has contracted by 25% YoY

Efficiency

How efficient is Vivani Medical business performance
The return on equity has dropped by 185% year-on-year and by 8% since the previous quarter
Vivani Medical's return on invested capital has surged by 93% YoY and by 24% QoQ
The return on assets has dropped by 60% year-on-year but it has increased by 5% since the previous quarter

Dividends

What is VANI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for VANI.

Financial health

How did Vivani Medical financials performed over time
The total assets is 114% more than the total liabilities
The company's quick ratio rose by 32% QoQ but it fell by 25% YoY
Vivani Medical's current ratio has increased by 27% QoQ but it has decreased by 26% YoY
The debt is 29% lower than the equity
The equity has grown by 38% from the previous quarter but it has contracted by 25% YoY
VANI's debt to equity is down by 29% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.